Cargando…
Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic Evidence
INTRODUCTION: The goal of chronic hepatitis C (CHC) treatment is to achieve a sustained virologic response (SVR). The new generation of direct-acting antivirals (DAAs) offers 90–100% SVR rates. However, access to these treatments is generally limited to patients with advanced liver disease. The aim...
Autores principales: | Nuño Solinís, Roberto, Arratibel Ugarte, Patricia, Rojo, Ander, Sanchez Gonzalez, Yuri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125137/ https://www.ncbi.nlm.nih.gov/pubmed/27783223 http://dx.doi.org/10.1007/s40121-016-0134-x |
Ejemplares similares
-
Comment on Nuño Solinís R, et al. “Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic Evidence”
por: Cacoub, Patrice
Publicado: (2017) -
Advancing Towards Value-Based Integrated Care for Individuals and Populations
por: Nuño-Solinís, Roberto
Publicado: (2019) -
Mental Illness Inequalities by Multimorbidity, Use of Health Resources and Socio-Economic Status in an Aging Society
por: García-Goñi, Manuel, et al.
Publicado: (2021) -
Integrated end of life care: the role of social services
por: Nuño-Solinís, Roberto
Publicado: (2014) -
Revisiting Organisational Learning in Integrated Care
por: Nuño-Solinís, Roberto
Publicado: (2017)